fda warning unapproved peptides bpc-157 tb-500 compounding panel on will include experts who promote the unproven chemicals favored by RFK Jr BPC-157 vs TB-500: Complete Comparison
Description
Neurological symptoms such as numbness, tingling in the hands or feet, muscle weakness, balance problems, or difficulty walking can occur
References The Lancet (2023) Rosenstock J, et al
All subjects were divided into 6 groups one group was presented with saline placebo, and the rest were given different peptide concentrations
Some are prepared through compounding pharmacies, which operate under a different set of regulatory standards than pharmaceutical manufacturers
Most common doses fall in the easy-to-read range of 5-25 units
